Exagen Inc. Announces Third Quarter Financial Results
Exagen Inc. (Nasdaq: XGN), a prominent player in autoimmune testing, is gearing up to disclose its financial performance for the quarter ending September 30. This announcement will occur before market opening on an upcoming Tuesday, marking a pivotal moment for the company as it updates stakeholders on its progress.
Leadership Conference Call Details
On this significant date, John Aballi, the President and Chief Executive Officer of Exagen, along with Jeff Black, the Chief Financial Officer, will host a conference call to discuss the company’s financial results. The call is scheduled for 8:30 a.m. ET, which is 5:30 a.m. PT. This session will provide insights into the company's financial health and future outlook, emphasizing its ongoing commitment to innovation in autoimmune diagnostics.
How to Join the Conference Call
Participants interested in joining the call can utilize the following dial-in numbers:
- U.S. Dial-In: 201-389-0918
- International Dial-In: 877-407-0890
Additionally, a live webcast of the call will be accessible through Exagen’s investor relations website, allowing broader engagement from stakeholders interested in the company's developments.
Accessing the Replay
For those unable to attend the live call, a replay will be available for a limited time. Stakeholders can listen to the recording until a specified date, which provides a great opportunity to stay informed.
- U.S. Replay: 201-612-7415
- International Replay: 877-660-6853
- Replay Passcode: 13756599
Moreover, the webcast archive will be available approximately one hour after the conclusion of the call, enabling a convenient way for interested parties to catch up on the key discussions and data shared.
About Exagen Inc.
Exagen Inc. stands at the forefront of autoimmune diagnostics, striving to enhance the diagnostic process for chronic autoimmune conditions. With a strong emphasis on patient care and innovation, Exagen's flagship product, AVISE CTD, offers clinicians vital tools to diagnose complex autoimmune diseases like lupus and rheumatoid arthritis with enhanced precision. The company operates a CLIA-certified, CAP-accredited laboratory, which bolsters its capability in delivering timely and accurate test results.
Committed to Patient-Centered Care
As a dedicated entity in the healthcare landscape, Exagen continuously invests in research and innovation, aiming to transform the management of autoimmune diseases. By offering a robust suite of AVISE-branded tests, the company not only aids in disease diagnosis but also plays a critical role in disease monitoring and prognosis, addressing the pressing needs of clinicians and patients alike.
With an ongoing commitment to educational initiatives, Exagen ensures that both patients and healthcare professionals are well-equipped with the knowledge necessary for effective autoimmune disease management, fostering a deeper understanding of these complex conditions.
Stay Informed with Exagen Inc.
For more insights into Exagen Inc. and its pioneering work in autoimmune diagnostics, interested individuals can explore Exagen's official website or follow the company on various social media platforms.
Company Contact Information
For inquiries, stakeholders are encouraged to connect with Ryan Douglas at Exagen Inc. via the email contact provided. This open line allows for direct communication, ensuring that questions and concerns are addressed promptly.
Frequently Asked Questions
1. When will Exagen announce its financial results?
Exagen Inc. will announce its financial results for the third quarter on an upcoming Tuesday, before the market opens.
2. Who will be hosting the conference call?
The conference call will be hosted by John Aballi, the President and Chief Executive Officer, and Jeff Black, the Chief Financial Officer.
3. How can I listen to the conference call?
You can join the conference call via U.S. or international dial-in numbers or by accessing the live webcast on Exagen’s investor relations website.
4. Is there a replay available for the conference call?
Yes, a replay of the conference call will be available for a limited time after the event.
5. What does Exagen Inc. specialize in?
Exagen Inc. specializes in autoimmune diagnostics, providing innovative testing solutions for chronic autoimmune diseases.
